Merck Extends Timeline On Acceleron Deal, Still Expects Q4 Close
Some Investors Have Voiced Concern About Buyout
Merck said it is giving the FTC more time to review the acquisition, but the shift also gives the company leeway to convince any reluctant Acceleron shareholders to trade their shares for cash.
